Spain· ES:113842003
Incresync 12,5 mg/30 mg comprimidos recubiertos con pelicula
A medicinal product containing pioglitazona + alogliptina, registered in Spain by Takeda Pharma A/S.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- pioglitazona + alogliptina
- Manufacturer
- Takeda Pharma A/S
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo70119928EUR 24.48
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pioglitazona + alogliptina in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenIncresync 12,5 mg/30 mg Filmdragerad tablettTakeda Pharma A/S
- IcelandIncresyncTakeda Pharma A/S*
- NetherlandsIncresync 12,5 mg/30 mg filmomhulde tabletTakeda Pharma A/S
- PolandIncresyncTakeda Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Incresync
- Liechtenstein · Incresync
- Norway · Incresync
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6035b9b9-cadb-40cc-9ec4-74dd06fe466c GET /v1/drugs/6035b9b9-cadb-40cc-9ec4-74dd06fe466c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1389826800000}",
"nregistro": "113842003",
"substance": "pioglitazona + alogliptina"
}See everything about pioglitazona + alogliptina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.